Sat.Apr 10, 2021 - Fri.Apr 16, 2021

article thumbnail

GDPR represents an “urgent threat” to the EU’s research leadership role

pharmaphorum

More than 5,000 collaborative studies were thwarted by GDPR rules in 2019 – but is there a way to protect sensitive data while still allowing international health research to thrive? . A coalition of European academy networks has called upon European Union (EU) leaders to rethink how General Data Protection Regulation (GDPR) rules are applied to health data.

145
145
article thumbnail

Vaccines Won’t Protect Millions of Patients With Weakened Immune Systems

NY Times

Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Take the next step into CROY 2021

Pharma Times

The 2021 Clinical Researcher of the Year – The Americas competition is reaching out to the very best in the industry to take the next step and claim gold.

121
121
article thumbnail

Thermo Fisher Scientific snaps up PPD in $17.4b acquisition deal

Outsourcing Pharma

The science service and technologies firm plans to bring the CRO under its Laboratory Products and Services Segment umbrella after the deal is completed.

116
116
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Apple, Google block NHS contact tracing app update on privacy grounds

pharmaphorum

A scheduled update to the NHS COVID-19 app has been blocked because it allows location tracking – something prohibited by Apple and Google, which developed some of the code it uses. . The new version of the app used in England and Wales was due to become available today to coincide with the relaxation of lockdown rules, with the public now able to attend venues such as non-essential shops, pub beer garden, gyms and hairdressers.

138
138
article thumbnail

6 Digital Tools at the Center of Healthcare Digitalization [INFOGRAPHIC]

Pharma Marketing Network

Over the last year, we witnessed a massive shift to digital technologies in the health industry – trends that were gradually making their ways suddenly moved into prompt adoption due to the immense limitations brought by the COVID-19 pandemic. Download this infographic and learn which 6 digital tools are at the center of digitalization and how the will influence the future of Pharma marketing in 2021 and beyond.

More Trending

article thumbnail

Vaccines Won’t Protect Millions of Patients With Crippled Immune Systems

NY Times

Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.

article thumbnail

The power of communication: engaging diverse groups in healthcare

pharmaphorum

Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society – especially in healthcare. Page & Page’s Lisa Jane Lishman outlines why communication and the strategies behind it need to be more personal to ensure that people – whoever they are – feel valued and respected.

article thumbnail

Protected: Health Psychology – the Solution to First Fill Abandonment?

Pharma Marketing Network

This content is password protected. To view it please enter your password below: Password: The post Protected: Health Psychology – the Solution to First Fill Abandonment? appeared first on Pharma Marketing Network.

96
article thumbnail

Magic mushroom compound psilocybin shows ‘promise’ in depression

Pharma Times

Researchers from Imperial College London say compound is at least as effective as a leading antidepressant in a therapeutic setting

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Cyclica teams with academics to investigate COVID-19 treatment

Outsourcing Pharma

The drug-discovery firm has partnered with several academic institutions to explore a Novartis lung-cancer treatmentâs potential in treating COVID-19.

98
article thumbnail

Exscientia starts trials of first AI-derived cancer immunotherapy

pharmaphorum

Exscientia was the first company to start human trials of a new drug designed using artificial intelligence (AI) last year, and now says it has started testing of the first AI candidate for immuno-oncology. . Oxford, UK-based Exscientia has been working with German biotech Evotec on the adenosine A2a receptor antagonist, which is being tested as a treatment for adult patients with advanced solid tumours.

article thumbnail

Tune In: Key Learnings and Insights from Leaders in Native Advertising

Pharma Marketing Network

Native advertising may mean something different to you depending on what part of the industry you’re in whether it be in advertising or publishing. . Tune in and listen to the Pharma Marketing Network and fellow thought leaders from, ROI Marketplace, MedThink, and Sharecare.com, discuss their learnings and insights on native advertising from each of their respective vantage points – pharma-marketer, publisher, and agency. .

article thumbnail

Pfizer, Myovant begin dosing in relugolix contraceptive study

Pharma Times

Dosing has begun in a Phase III study evaluating the contraceptive efficacy of relugolix combination tablet

121
121
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Decentralized trials call for supply chain flexibility: Marken

Outsourcing Pharma

Leaders from the supply chain solutions company share their thoughts on challenges associated with virtual and hybrid trials, and the COVID-19 pandemic.

93
article thumbnail

Risk of brain clots higher with COVID than vaccine, study suggests

pharmaphorum

A study has suggested that the risk of getting a serious brain clot is eight to 10 times higher in people with COVID-19 than those who get a vaccine. There are some big caveats with the research from Oxford University – it was based on data from people in the US who had received either a Pfizer or Moderna vaccine – but the team said findings could reassure people about the safety of vaccines.

Vaccines 105
article thumbnail

Worry Over 2 Covid Vaccines Deals Fresh Blow to Europe’s Inoculation Push

NY Times

Confusion over AstraZeneca’s vaccine threatens to hurt the E.U. campaign just as it gathers momentum. And on Tuesday, Johnson & Johnson said it was pausing the rollout of its shot on the continent.

article thumbnail

Inhaled asthma drug accelerates recovery from COVID-19

Pharma Times

Self-reported recovery was three days shorter for patients receiving inhaled budesonide

129
129
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

PPD, Clinical Ink join on lupus assessment and endpoint data

Outsourcing Pharma

The two companies have partnered to develop a systemic erythematosus assessment review to streamline clinical trials centered on the autoimmune disease.

88
article thumbnail

Romark eyes FDA okay for COVID antiviral despite mixed trial results

pharmaphorum

A phase 3 trial of Romark’s antiviral drug NT-300 has missed the main objective in a phase 3 trial in mild to moderate COVID-19 patients, but could still have a shot at emergency use authorisation (EUA), according to the US company. . The Florida-based firm has just released top-line results from the 1,092-patient study , showing that patients treated NT-300 – an orally-active, long-acting formulation of the established drug nitazoxanide – didn’t differ significantly from a placebo group i

Hospitals 105
article thumbnail

Changing Strategy, the E.U. Bets Big on Pfizer to Battle Covid

NY Times

After an early focus on AstraZeneca and months of turmoil, the European Union is pivoting away from the company’s vaccine. It has reached agreement for a faster rollout of the Pfizer-BioNTech shot.

article thumbnail

New subcutaneous formulation of Tysabri approved in UK

Pharma Times

Multiple sclerosis treatment can now be administered subcutaneously or intravenously

124
124
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Decentralized trial model pushing research to ‘new standard’: AiCure

Outsourcing Pharma

A leader from the trial tech firm says COVID-19 has accelerated virtual studies, creating opportunities to improve patient engagement, costs and data.

79
article thumbnail

Cytisinicline – the solution to stop smoking?

pharmaphorum

Whether present in electronic or combustible cigarettes, nicotine is a highly addictive substance. Dr Cindy Jacobs, chief medical officer of Achieve Life Sciences discusses the potential of cytisinicline therapy for smoking cessation. . Although e-cigarettes are considered a less dangerous alternative to combustible cigarettes, they can still result in, or sustain, nicotine addiction, for which the long-term safety issues and associated health risks are unknown.

article thumbnail

US Calls for Pause in Johnson & Johnson Shot

NY Times

Johnson & Johnson’s single-dose Covid-19 shots were halted in much of the nation on Tuesday after federal health agencies called for a pause in their use after a rare blood clotting disorder in six people.

56
article thumbnail

Gilead’s Trodelvy scores accelerated approval in advanced bladder cancer

Pharma Times

US Food and Drug Administration approved antibody drug conjugate based on Phase II trial results

117
117
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Which pharmaceutical drugs have the most drug patents in South Korea?

Drug Patent Watch

This chart shows the drugs with the most patents in South Korea. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical drugs have the most drug patents in South Korea? appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

Czech Republic swoops for Denmark’s 2.4m unwanted AZ COVID shots

pharmaphorum

The Czech Republic wants to buy around 2.4 million doses of the AstraZeneca/Oxford University vaccine ditched by Denmark, which has said it will stop using it because of concerns about rare blood clotting side-effects. Czech deputy prime minister Jan Hamacek said on twitter that he had instructed the country’s ambassador in Denmark to try to buy the unwanted doses.

article thumbnail

Medical Equipment: Should You Buy, Lease, or Just Wait?

Pharma Mirror

Running a healthcare business is a tricky thing. Certain equipment is often being requested by physicians who are insisting it’s needed to improve patient diagnosis and care. Yet, it’s not always affordable. Other times, it’s preferred, but the business should be mindful of the cost and look at how best to afford it. Should medical equipment be purchased outright, leased, and then acquired or delayed until it’s more affordable?

52
article thumbnail

Four medicines accepted for use by NHS Scotland

Pharma Times

Newly accepted medicines include treatments for multiple myeloma and severe migraine

119
119
article thumbnail

New patent for Helsinn Hlthcare drug AKYNZEO

Drug Patent Watch

Annual Drug Patent Expirations for AKYNZEO Akynzeo is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It is available from one supplier. There are seventeen patents…. The post New patent for Helsinn Hlthcare drug AKYNZEO appeared first on DrugPatentWatch - Make Better Decisions.

52